SULLIVAN MARK (Chief Legal Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/13/2025ACC: 0000950170-25-038798
Officer· Chief Legal Officer
Since Feb 2026
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
86.6%
3/12/2025
173.20K→323.20K
Total
Net shares
+150K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/12/2025 | A · Award | +150K | — | — | 86.6% | 173.20K | 323.20K |
| Total | +150K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported